-
www.ahrq.gov/hai/cusp/cauti-interim/cauti-interim5.html
July 01, 2013 - Eliminating CAUTI: Interim Data Report
Conclusions
Previous Page
Table of Contents
Eliminating CAUTI: Interim Data Report
Executive Summary
Introduction and Objectives
Methods
Results
Outcome and Process Measures
Culture Measures
Conclusions
The national project team …
-
www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patient-family-engagement/pfeprimarycare/medication-mgmt-sample-process.pdf
June 02, 2025 - Medication Management: Sample Process for Medication Management Strategy
Sample Process for
Medication Management Strategy
Introduction
The Medication Management strategy is an effort to engage patients and families to actively
participate with you in developing a complete and accurate medication list from which …
-
www.ahrq.gov/ncepcr/tools/obesity/obpcp2.html
May 01, 2014 - Integrating Primary Care Practices and Community-based Resources to Manage Obesity
Chapter 2: Building and Assessing the Clinic Foundation
Previous Page Next Page
Table of Contents
Integrating Primary Care Practices and Community-based Resources to Manage Obesity
Acknowledgements
Support
Forew…
-
hcup-us.ahrq.gov/toolssoftware/comorbidity/comformat2012-2015.txt
January 01, 2015 - /******************************************************************/
/* Title: CREATION OF FORMAT LIBRARY FOR ELIXHAUSER COMORBIDITY GROUPS */
/* ELIXHAUSER COMORBIDITY SOFTWARE, VERSION 3.7 */
/* */
/* Description: …
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-208-bipolar-adults-disposition-comments.pdf
August 07, 2018 - industry-funded trials which were conducted with the clear
intent of securing FDA approval for a given indication … the publication, however; this DB trial was one of
the pivotal trials supporting the bipolar mania indication … 25 years has consisted of industry-funded
clinical trials with a narrow focus (typically a new FDA indication
-
digital.ahrq.gov/sites/default/files/docs/publication/r01hs015175-weissman-final-report-2007.pdf
January 01, 2007 - E-prescribing Impact on Patient Safety, Use and Cost
Grant Final Report
Grant ID: 5 R01 HS015175-02
E-prescribing Impact on Patient Safety, Use and Cost
Inclusive dates: 09/03/04 - 12/31/07
Principal Investigator:
Joel S. Weissman, PhD
Team members:
Christine Vogeli, PhD
Michael Fi…
-
www.ahrq.gov/sites/default/files/2024-09/linzer-schwartz-report.pdf
January 01, 2024 - Final Progress Report: Minimizing Error, Maximizing Outcome (MEMO): The Physician Worklife Study II
Minimizing Error, Maximizing Outcome (MEMO): Physician Worklife Study II
Mark Linzer, MD, Principal Investigator (University of Wisconsin-Madison)
Mark Schwartz, MD, Co-Principal Investigator (New York Universi…
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-143-fullreport.pdf
April 01, 2018 - Global Assessment of Pediatric Patient Safety (GAPPS) Trigger Tool
1
Global Assessment of Pediatric Patient Safety
(GAPPS) Trigger Tool
Section 1. Basic Measure Information
1.A. Measure Name
Global Assessment of Pediatric Patient Safety (GAPPS) Trigger Tool
1.B. Measure Number
0143
1.C. Measure Description
…
-
www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/NCINQTobaccoUseHelpForm.pdf
August 01, 2012 - NCINQ Measure Submission: Tobacco Use and Help with Quitting Among Adolescents
Attachment A: CHIPRA Pediatric Quality Measures Program (PQMP) Candidate
Measure Submission Form (CPCF)
Italics indicate instructions for how to complete a specific field. << >> indicates the name of a text field in the
online version o…
-
digital.ahrq.gov/sites/default/files/docs/publication/u18hs016394-lapane-final-report-2006.pdf
January 01, 2006 - such, estimation of potentially inappropriate medications is
limited to medications for which an indication
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/pediatric-ehr_research-protocol.pdf
January 01, 2014 - design, year, setting, geographic
location, and duration; b) population information including patient indication
-
psnet.ahrq.gov/web-mm/perioperative-anaphylaxis-after-insertion-latex-drain-patient-known-latex-allergy
July 08, 2022 - November 30, 2012
Documenting the indication for antimicrobial prescribing: a scoping
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/nppv-respiratory-failure_research-protocol.pdf
April 21, 2011 - Although non-RCTs may be particularly pertinent to
addressing effectiveness, confounding by indication
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/distributed-network-blueprint_research.pdf
June 01, 2010 - angiotensin-converting enzyme
(ACE) inhibitor as second line antihypertensive therapy, omitting those with an
indication
-
www.ahrq.gov/sites/default/files/2024-02/taber-report.pdf
January 01, 2024 - Clinical medication errors included duplicate therapy,
no indication, untreated condition, high/low
-
www.ahrq.gov/ncepcr/tools/workforce-financing/case-example-3.html
July 01, 2019 - following a scripted and logical sequence of events, and documenting all drug therapy problems from indication
-
www.ahrq.gov/research/findings/final-reports/stpra/stpraapa3.html
April 01, 2018 - Procedure level (for peri and postoperative surgeries): type and indication of surgery performed, type
-
www.ahrq.gov/news/events/ahrq-research-summit-diagnostic-safety-biosketches.html
September 01, 2016 - and a new AHRQ HIT Safety project to enhance electronic prescribing safety by incorporating the drug indication
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/folic-acid-for-the-prevention-of-neural-tube-defects-preventive-medication
August 01, 2023 - NTDs by dosage, duration, and timing
Dosage: 4 studies (1 cohort, 3 case-control); n = 26,791
No indication
-
www.ahrq.gov/sites/default/files/wysiwyg/cahps/cahps-database/2020_hp_chartbook.pdf
January 01, 2020 - end of each section, there is table that provides the number of plans
and respondents to provide an indication